by Brandon Tudor | Feb 15, 2026 | Blog
Ways to frame liver disease symptoms There are two key categories: 1) Usually no symptoms earlyFatty liver disease often has no noticeable symptoms until it progresses. Most people are diagnosed via routine blood tests or imaging, not symptoms. 2) Possible...
by Brandon Tudor | Feb 11, 2026 | Blog
Here’s a summary of the Gastroenterology Advisor article “Cannabis Use Linked to Better Hepatic Outcomes, Worse Cardiovascular Outcomes in MASLD” — Key Findings from the Study Population studied: >3.3 million adults hospitalized with MASLD between...
by Brandon Tudor | Feb 3, 2026 | Blog
The HEP Mag article “Closing equity gaps in cirrhosis & liver cancer care” is eye-opening. Summary: Closing Equity Gaps in Cirrhosis and Liver Cancer Care Two new studies from UT Southwestern highlight how trust, communication, health literacy, and access to...
by Brandon Tudor | Jan 27, 2026 | Blog
Here’s a summary of the Diabetes In Control article about GLP-1 drugs and liver disease titled “GLP‑1s and Liver Disease: Rethinking MASLD Care Beyond Obesity and A1C.” 📌 The Core Message GLP-1 receptor agonists — originally developed for type 2 diabetes...
by Brandon Tudor | Jan 22, 2026 | Blog
The European Medical Journal 01/21/2026 article entitled “Both long and short sleep duration linked to liver disease” has new information. Key Findings A recent population-level analysis found that both short and long habitual sleep durations are...
